Clinical Cancer Research, Vol 4, Issue 7 1591-1595, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer

SR Evans, J Nolla, J Hanfelt, M Shabahang, RJ Nauta and IB Shchepotin
Department of Surgery, George Washington University Medical Center, Washington, DC 20037, USA. sursre@gwumc.edu

To date, none of the potential biological markers in colorectal cancer attempts to link the epidemiological data with the molecular biology of the disease. In an attempt to link dietary and epidemiological factors and to obtain a better understanding of the molecular biology of colorectal cancer, we measured vitamin D receptor (VDR) expression in 75 human colorectal cancers as a potential predictive marker of the biological behavior of the disease. Our results showed that a high level of VDR expression was associated with a favorable prognosis. The results of the studies reinforce the potential role that VDR may play in the development of the pathogenesis of colorectal cancer. Larger studies looking exclusively at stage I and stage II disease will hopefully lead to the development of a sensitive hormonal marker that can be used to predict the biological behavior of colorectal cancer, identifying at-risk patients in need of adjuvant treatment.

This article has been cited by other articles:

				M. J. Larriba, N. Valle, H. G Palmer, P. Ordonez-Moran, S. Alvarez-Diaz, K.-F. Becker, C. Gamallo, A. G. de Herreros, J. M. Gonzalez-Sancho, and A. Munoz The inhibition of Wnt/{beta}-catenin signalling by 1{alpha},25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells Endocr. Relat. Cancer, March 1, 2007; 14(1): 141 - 151. [Abstract] [Full Text] [PDF]

				R. Maruyama, F. Aoki, M. Toyota, Y. Sasaki, H. Akashi, H. Mita, H. Suzuki, K. Akino, M. Ohe-Toyota, Y. Maruyama, et al. Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation. Cancer Res., May 1, 2006; 66(9): 4574 - 4583. [Abstract] [Full Text] [PDF]

				G. Bises, E. Kallay, T. Weiland, F. Wrba, E. Wenzl, E. Bonner, S. Kriwanek, P. Obrist, and H. S. Cross 25-Hydroxyvitamin D3-1{alpha}-hydroxylase Expression in Normal and Malignant Human Colon J. Histochem. Cytochem., July 1, 2004; 52(7): 985 - 989. [Abstract] [Full Text] [PDF]

				C-M Huang, M-C Wu, J-Y Wu, and F-J Tsai Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus Lupus, January 1, 2002; 11(1): 31 - 34. [Abstract] [PDF]

				P. A. Hershberger, R. A. Modzelewski, Z. R. Shurin, R. M. Rueger, D. L. Trump, and C. S. Johnson 1,25-Dihydroxycholecalciferol (1,25-D3) Inhibits the Growth of Squamous Cell Carcinoma and Down-Modulates p21Waf1/Cip1 in Vitro and in Vivo Cancer Res., June 1, 1999; 59(11): 2644 - 2649. [Abstract] [Full Text] [PDF]

				H. G. Palmer, J. M. Gonzalez-Sancho, J. Espada, M. T. Berciano, I. Puig, J. Baulida, M. Quintanilla, A. Cano, A. G. de Herreros, M. Lafarga, et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of {beta}-catenin signaling J. Cell Biol., July 23, 2001; 154(2): 369 - 388. [Abstract] [Full Text] [PDF]